CONSOLIDATED BALANCE SHEETS - USD ($)	Nov. 30, 2025	Aug. 31, 2025
Current
Cash	$ 4,281,233	$ 1,802,123
Short-term investments	143,267	143,267
Marketable securities	0	22,093
Accounts receivable	88,044	368,358
Prepaid expenses and other current assets	850,585	1,132,504
Total Current Assets	5,363,129	3,468,345
Non-current assets, net
Long-term receivables	64,013	64,013
Right of use assets	99,485	106,816
Intellectual property, net	308,060	307,818
Property & equipment, net	216,120	228,129
Total Non-Current Assets	687,678	706,776
TOTAL ASSETS	6,050,807	4,175,121
Current Liabilities
Accounts payable and accrued liabilities	1,425,433	1,463,046
Lease liability, current	31,101	30,417
Total Current Liabilities	1,456,534	1,493,463
Lease liabilities - non-current	70,819	78,903
TOTAL LIABILITIES	1,527,353	1,572,366
Stockholders' Equity
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 22,225,846 and 19,559,179 at November 30, 2025 and August 31, 2025, respectively	22,226	19,559
Additional paid-in capital	70,022,365	66,501,086
Accumulated Deficit	(65,055,620)	(63,460,613)
Accumulated other comprehensive loss	(76,079)	(70,335)
Equity attributable to shareholders of Lexaria	4,912,892	2,989,697
Non-controlling Interest	(389,438)	(386,942)
Total Stockholders' Equity	4,523,454	2,602,755
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 6,050,807	$ 4,175,121